In the spring of 2021, the cancer field was abuzz over research that suggested a simple early-detection blood test could find dozens of different cancers, including many for which there is no routine screening.Four and a half years later, the chatter has only gotten louder. The maker of the test, called Galleri, released new data suggesting its performance had...